Related references
Note: Only part of the references are listed.Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP
T. Oka et al.
ONCOGENE (2012)
Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein
Bin Zhao et al.
GENES & DEVELOPMENT (2011)
Yes-Associated Protein Regulation of Adaptive Liver Enlargement and Hepatocellular Carcinoma Development in Mice
Marta A. Kowalik et al.
HEPATOLOGY (2011)
Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
Siew Wee Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor
Murugan Paramasivam et al.
MOLECULAR BIOLOGY OF THE CELL (2011)
PP1A-Mediated Dephosphorylation Positively Regulates YAP2 Activity
Pei Wang et al.
PLOS ONE (2011)
MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties
Angela M. Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Functional complexes between YAP2 and ZO-2 are PDZ domain-dependent, and regulate YAP2 nuclear localization and signalling
Tsutomu Oka et al.
BIOCHEMICAL JOURNAL (2010)
Targeting YAP and Hippo signaling pathway in liver cancer
Angela M. Liu et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver
Samira Benhamouche et al.
GENES & DEVELOPMENT (2010)
Structural insights into the YAP and TEAD complex
Ze Li et al.
GENES & DEVELOPMENT (2010)
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF beta-TRCP
Bin Zhao et al.
GENES & DEVELOPMENT (2010)
Structural and functional analysis of the YAP-binding domain of human TEAD2
Wei Tian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver
Li Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis
Kwang-Pyo Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene
Dawang Zhou et al.
CANCER CELL (2009)
MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer
Kuen-Haur Lee et al.
EXPERIMENTAL CELL RESEARCH (2009)
Phase II Trial of the Combination of Bevacizumab and Erlotinib in Patients Who Have Advanced Hepatocellular Carcinoma
Melanie B. Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2
Wha Ja Cho et al.
MOLECULES AND CELLS (2009)
RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network
Cai Guo et al.
CURRENT BIOLOGY (2007)
Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity
JP McPherson et al.
EMBO JOURNAL (2004)
Share Paper
